Xu Haowen, Wang Li, Guan Sheng, Li Dongdong, Quan Tao
Department of Neurointerventional Radiology, The First Affiliated Hospital of Zhengzhou University, Road Jianshe No 1, Zhengzhou City, 450052, China.
Department of Neurology, Children Hospital of Zhengzhou City, Zhengzhou City, China.
Neuroradiology. 2018 Aug;60(8):853-859. doi: 10.1007/s00234-018-2049-6. Epub 2018 Jun 29.
Periprocedural symptomatic intracranial hemorrhage (sICH) unrelated to coil embolization of intracranial aneurysm has been rarely reported. The incidence and characteristics of this complication remain unclear. This study was designed to elucidate the incidence and characteristics of periprocedural sICH unrelated to coiling of intracranial aneurysm, and to explore the possible mechanisms underlying this complication.
Included in this retrospective study were 1287 patients with 1394 aneurysms who were treated with coil embolization (476 patients with stent assistance and 811 patients without stents) between May 2008 and August 2017. All procedure-unrelated sICHs that occurred within 30 days after coiling were selected. The technical details of the procedure, clinical characteristics, and medical therapy were recorded.
A total of 6 patients developed periprocedural sICH unrelated to coil embolization. All these six patients underwent stent-assisted coiling (SAC). Therefore, there was a 1.3% (6/476) procedure-unrelated sICH rate of SAC and 0% (0/811) in patients underwent coiling without stent during the periprocedural period (P = 0.005, RR 0.987; 95% CI, 0.977-0.997). These phenomena occurred more often in patients who received SAC for ruptured aneurysms vs patients underwent this technique for unruptured aneurysms (2.0 vs 0.7%, P = 0.390, RR 2.896; 95% CI, 0.525-15.968). All these phenomena occurred within 7 days after coiling, and resulted in one mortality, one unfavorable outcome (mRS Score 3), and other four favorable outcomes (mRS Scores 0-2) at 90 days after procedure.
Our findings suggest that the procedure-unrelated sICH, though less frequent, may exist following stent-assisted coiling of intracranial aneurysm during the periprocedural period. Extra caution may be warranted in patients who were treated with SAC for ruptured aneurysms.
与颅内动脉瘤弹簧圈栓塞无关的围手术期症状性颅内出血(sICH)鲜有报道。该并发症的发生率及特征仍不明确。本研究旨在阐明与颅内动脉瘤弹簧圈栓塞无关的围手术期sICH的发生率及特征,并探究该并发症可能的潜在机制。
本回顾性研究纳入了2008年5月至2017年8月期间接受弹簧圈栓塞治疗的1287例患者的1394个动脉瘤(476例患者接受支架辅助,811例患者未接受支架)。选取了所有在弹簧圈栓塞后30天内发生的与手术无关的sICH。记录手术的技术细节、临床特征及药物治疗情况。
共有6例患者发生了与弹簧圈栓塞无关的围手术期sICH。这6例患者均接受了支架辅助弹簧圈栓塞(SAC)。因此,围手术期SAC与手术无关的sICH发生率为1.3%(6/476),未接受支架的弹簧圈栓塞患者为0%(0/811)(P = 0.005,RR 0.987;95% CI,0.977 - 0.997)。与接受SAC治疗未破裂动脉瘤的患者相比,接受SAC治疗破裂动脉瘤的患者中这些现象更常见(2.0%对0.7%,P = 0.390,RR 2.896;95% CI,0.525 - 15.968)。所有这些现象均发生在弹簧圈栓塞后7天内,术后90天时导致1例死亡、1例不良预后(改良Rankin量表评分3分)以及其他4例良好预后(改良Rankin量表评分0 - 2分)。
我们的研究结果表明,与手术无关的sICH虽不常见,但在围手术期颅内动脉瘤支架辅助弹簧圈栓塞后可能存在。对于接受SAC治疗破裂动脉瘤的患者可能需要格外谨慎。